CervoMed Announces Last Patient Last Visit in Phase 2b RewinD LB Trial[...]
Lexaria Announces $5 Million Registered Direct Offering Priced At The[...]
10/15/2024 | Press release | Distributed by Public on 10/15/2024 06:15
Please select the service you want to use:
Smartlinks | Concentrix Corporation | News | Securities Issuers | Data Processing Companies | Frankfurt Stock Exchange | Dusseldorf Stock Exchange | Stuttgart Stock Exchange | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact